Home Press Release north-america-bronchiectasis-market
Press Release

Nov, 06 2023

A AstraZeneca, a GlaxoSmithKline Plc e a Teva Pharmaceutical Industries Ltd estão a dominar o mercado da bronquiectasia na América do Norte em 2020.

Prevê-se que o mercado da bronquiectasia na América do Norte cresça com um CAGR de 6,1% no período previsto de 2021 a 2028. Os anos considerados para o estudo são os mencionados abaixo.

Aceda ao relatório completo em https://www.databridgemarketresearch.com/reports/north-america-bronchiectasis-market

O mercado norte-americano da bronquiectasia é um mercado altamente consolidado, que inclui um número específico de participantes importantes. O mercado testemunhou um aumento do desenvolvimento estratégico devido ao cenário de mercado favorável.    

Os principais participantes do mercado da bronquiectasia na América do Norte estão a introduzir uma vasta gama de fornecedores de produtos, além de lançarem novos produtos e adotarem iniciativas estratégicas, tais como aquisições e acordos no mercado. Isto ajudou as empresas a maximizar as vendas com um portfólio de produtos melhorado.

Por exemplo;

A AstraZeneca é a empresa dominante no mercado da bronquiectasia na América do Norte. Os outros principais participantes do mercado incluem a Abbott, HERSILL, Home Oxygen Company, Inogen, Inc., Boehringer Ingelheim International GmbH, Medline Industries, Inc, Ache Laboratories Farmaceuticos SA, Horizon Therapeutics plc, Johnson & Johnson, Inc. Trudell Medical International, GlaxoSmithKline plc., Pfizer Inc., Merck Sharp & Dohme Corp., uma subsidiária da Merck & Co., Inc., Novartis AG, Teva Pharmaceutical USA Inc. (uma subsidiária da Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Bayer AG, Dr. Reddy's Laboratories Ltd., Sunovion Pharmaceuticals Inc. (uma subsidiária da Sumitomo Dainippon Pharma Co., Ltd.), Viatris Inc., Zydus Pharmaceuticals, Inc. (uma subsidiária da Zydus Cadila), Cipla Inc. Electromed, Inc., entre outros.

Mercado da bronquiectasia na América do NorteAstraZeneca

A AstraZeneca foi fundada em 1999 e tem sede em Cambridge, no Reino Unido. A empresa está focada no fabrico de medicamentos inovadores que são utilizados por milhões de pacientes em todo o mundo. A empresa tem várias categorias de produtos, incluindo doenças cardiovasculares, renais e metabólicas, oncologia, infeções e vacinas , neurociência, respiratórias, gastrointestinais, entre as quais a respiratória é a categoria focada no mercado.

Por exemplo,

  • Em junho de 2019, a AstraZeneca recebeu aprovação para o Breztri Aerosphere (PT010) no Japão para o tratamento da DPOC. O Breztri Aerosphere é composto por budesonida/glicopirrónio/fumarato de formoterol e tem-se mostrado uma nova opção de tratamento entre as pessoas que sofrem de inflamação pulmonar e outras doenças obstrutivas crónicas. Esta aprovação ajudou a empresa a obter vendas constantes ao expandir as suas vendas de produtos para várias regiões do mundo.

The company has presence across Africa, Americas, Asia-Pacific, Europe, Middle East and Africa. The company has various subsidiaries companies including AstraZeneca India Pvt. Limited (India), AstraZeneca Czech Republic s.r.o. (Czech Republic), AstraZeneca B.V. (Netherlands), AstraZeneca GmbH (Germany), AstraZeneca AUSTRALIA (Australia) among others.

GlaxoSmithKline plc

GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, United Kingdom. The company is focused to become one of the best company in the field of innovation, development of drugs and vaccines that will be beneficial to both patient and consumers. The company operates its business through three business segments which are pharmaceuticals, vaccines, and consumer healthcare among which pharmaceuticals is the market focused segment. The company has various product categories including prescription medicines, vaccines, consumer healthcare products, viiv healthcare, and stiefel dermatology in which prescription medicines is the market focused category.

For instance,

  • In September 2020, GlaxoSmithKline plc. received approval for Trelegy Ellipta from U.S FDA for treatment of asthma and other COPD disease in U.S. This approval paved the way for product approval and allowed the company to expand its portfolio of innovative medicines for patients suffering from respiratory diseases.

The company has presence across Africa, Asia & Middle East, Australasia, Europe, North America, South & Central America. The company has various subsidiaries including GlaxoSmithKline Pharmaceuticals Ltd (Mumbai), Tesaro (Waltham, Massachusetts, United States),GlaxoSmithKline Pakistan (Karachi, Pakistan), Stiefel Laboratories (North Carolina, United States), Allen & Hanburys (Ware, United Kingdom), among others

Teva Pharmaceutical USA  Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)

Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.) is headquartered in New Jersey, U.S. The company is focused on the development and production of affordable, high-quality generic drugs, innovative specialty pharmaceuticals and active pharmaceutical ingredients. The company is providing several products through three product categories including generic medicines, specialty medicines, biopharmaceuticals in which generic medicines and specialty medicines are the market focused categories.

For instance,

  • In July 2020, Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.) launched ProAir Digihaler (albuterol sulfate 117 mcg) inhalation powder, which is the first digital inhaler indicated for the treatment of respiratory problems in pediatric patients. This product launch helps the patients to control their drug dosage ad to manage their health conditions. This product launch boosted the company’s product portfolio and helped it to establish its footprint in the bronchiectasis market.

A empresa tem presença em toda a América do Norte.

CHOOSE LICENCE TYPE

  • 7000
  • 4800
  • 3000
  • 8000
  • 12000
Buy Now
Advance Formative Research Customization Request for bulk Reports
Banner

Latest Press Release

Rising Growth of Smart Homes and Smart City Initiatives is Driving the Global Smart Security Market
Key Industry Verticals Fueling Sustained Market Growth
Growth in Domestic Vehicle Manufacturing and Assembly Activities Fuels Market Growth
Surge in Demand for Luxury Cosmetic and Fragrance Packaging is the Driving Factor in the Market
Rising Demand for Advanced Driver Training and Safety Education Is Driving the Global Driving Simulator Market
Rapid Expansion of AI and Machine Learning Adoption Across Industries, Increasing the Need for Large Volumes of Accurately Labeled Training Data is the Driving Factor in the Market
VIEW ALL

Browse Related Press Release

YOU MAY ALSO BE INTERESTED IN

Client Testimonials

Claudio Rondena
Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Client Logo
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Client Logo
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Client Logo
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I'm glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Client Logo
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Client Logo
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Client Logo
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Client Logo
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Client Logo
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Client Logo
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It's been very helpful in our business planning and it well organized.

Client Logo
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Client Logo
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist, Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future